Jay D. Kranzler, CEO at CYPRESS BIOSCIENCE INC (CYPB), sold 5,000 shares at $8.37 ($42K) on 2007-01-22, disclosed to the SEC on 2007-01-24.
Scheduled sale ($42k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.37 | 100 | $837 | 2.0% |
| 2 | $8.38 | 400 | $3K | 7.9% |
| 3 | $8.39 | 100 | $839 | 2.0% |
| 4 | $8.40 | 200 | $2K | 4.0% |
| 5 | $8.41 | 600 | $5K | 12.0% |
| 6 | $8.42 | 300 |
| $3K |
| 6.0% |
| 7 | $8.43 | 200 | $2K | 4.0% |
| 8 | $8.44 | 900 | $8K | 18.0% |
| 9 | $8.45 | 300 | $3K | 6.0% |
| 10 | $8.46 | 300 | $3K | 6.0% |
| 11 | $8.47 | 700 | $6K | 14.0% |
| 12 | $8.48 | 200 | $2K | 4.0% |
| 13 | $8.49 | 500 | $4K | 10.1% |
| 14 | $8.51 | 200 | $2K | 4.0% |
| Total | $8.44 avg | 5,000 | $42K | 100% |
| Filing → |
| CYPB | SELL | 2010-12-29 | $162K | — | Filing → |
| CYPB | SELL | 2010-12-29 | $983K | — | Filing → |
| CYPB | SELL | 2009-08-04 | $652K | — | Filing → |